Early‐Onset Guillain‐Barré Syndrome Associated with Reactivation of Epstein‐Barr Virus Infection after Nonmyeloablative Stem Cell Transplantation
Open Access
- 1 October 2004
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (7) , 1076-1078
- https://doi.org/10.1086/424015
Abstract
We report a case of early-onset acute Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus (EBV) infection after nonmyeloablative stem cell transplantation (NST). Reactivation of EBV infection preceded disease onset, and the virus load increased concomitantly with disease progression (doubling time, 2.7 days). This case raises concern about the expanding scope of manifestations associated with reactivation of EBV infection after NST.Keywords
This publication has 12 references indexed in Scilit:
- Cytomegalovirus (CMV) Virus Load Kinetics to Predict Recurrent Disease in Solid‐Organ Transplant Patients with CMV DiseaseThe Journal of Infectious Diseases, 2002
- Prevention of Epstein-Barr virus–lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantationBlood, 2002
- Human Cytomegalovirus (HCMV) Replication Dynamics in HCMV‐Naive and ‐Experienced Immunocompromised HostsThe Journal of Infectious Diseases, 2002
- Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCTBlood, 2001
- Successful treatment of Epstein–Barr virus-induced transverse myelitis with ganciclovir and cytomegalovirus hyperimmune globulin following unrelated bone marrow transplantationBone Marrow Transplantation, 1999
- B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeBone Marrow Transplantation, 1999
- Guillain-Barré syndrome following allogeneic bone marrow transplantationNeurology, 1997
- REDUCED INCIDENCE OF EPSTEIN-BARR VIRUS-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER USING PREEMPTIVE ANTIVIRAL THERAPY1Transplantation, 1997
- Rapid Occurrence of Lymphoproliferative Disease After Pancreas-Kidney Transplantation Performed During Acute Primary Epstein-Barr Virus InfectionClinical Infectious Diseases, 1997
- Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantationBlood, 1988